Education
About Us
Working with TipRanks
Follow Us
CVS Health Corp (IT:1CVS)
:1CVS
1CVS Stock Chart & Stats
Day’s Range― - ―
52-Week Range€41.40 - €65.00
Previous CloseN/A
Volume0.00
Average Volume (3M)37.00
Market Cap
$68.37B
Enterprise Value€155.86B
Total Cash (Recent Filing)$12.65B
Total Debt (Recent Filing)$81.21B
Price to Earnings (P/E)14.1
Beta0.38
Next Earnings
Jul 30, 2025EPS Estimate
1.31Last Dividend Ex-Date
Apr 22, 2025Dividend Yield4.4%
Share Statistics
EPS (TTM)2.01
Shares Outstanding1,265,019,400
10 Day Avg. Volume17
30 Day Avg. Volume37
Financial Highlights & Ratios
PEG Ratio1.11
Price to Book (P/B)1.10
Price to Sales (P/S)0.00
P/FCF Ratio14.26
Enterprise Value/Market Cap2.28
Enterprise Value/Revenue0.11
Enterprise Value/Gross Profit2.93
Enterprise Value/Ebitda2.61
Forecast
1Y Price Target
$70.87Price Target Upside31.04% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering19
---
Bulls Say, Bears Say
Bulls Say
Earnings GuidanceCVS beat Q1 and increased guidance, but has modestly underperformed despite what was seen as a very constructive update.
Financial PerformanceCVS's improving profitability could drive multiple expansion, with more positive fundamental momentum and more tailwinds than headwinds across the business.
Health Care BenefitsCVS is well positioned to see material Health Care Benefits upside due to its conservative view on trends and favorable first-quarter results.
Bears Say
Earnings QualityUncertainty around earnings quality is likely a reason for CVS's modest underperformance.
Operational ChallengesThere are still some moving pieces like elevated utilization and challenges with Oak Street/Signify.
PBM ReformHeadline risk could arise around PBM reform/legislation seeking to break up PBM ownership of pharmacies.
---
Options Prices
Currently, No data available
---
Ownership Overview
1.02% Insiders
31.70%
Mutual Funds
0.43% Other Institutional Investors
46.48% Public Companies and
Individual Investors
1CVS FAQ
What was CVS Health Corp’s price range in the past 12 months?
CVS Health Corp lowest stock price was €41.40 and its highest was €65.00 in the past 12 months.
What is CVS Health Corp’s market cap?
CVS Health Corp’s market cap is $68.37B.
When is CVS Health Corp’s upcoming earnings report date?
CVS Health Corp’s upcoming earnings report date is Jul 30, 2025 which is in 75 days.
How were CVS Health Corp’s earnings last quarter?
CVS Health Corp released its earnings results on May 01, 2025. The company reported €2.01 earnings per share for the quarter, beating the consensus estimate of €1.521 by €0.489.
Is CVS Health Corp overvalued?
According to Wall Street analysts CVS Health Corp’s price is currently Undervalued.
Does CVS Health Corp pay dividends?
CVS Health Corp pays a Quarterly dividend of €0.594 which represents an annual dividend yield of 4.4%. See more information on CVS Health Corp dividends here
What is CVS Health Corp’s EPS estimate?
CVS Health Corp’s EPS estimate is 1.31.
How many shares outstanding does CVS Health Corp have?
CVS Health Corp has 1,265,019,400 shares outstanding.
What happened to CVS Health Corp’s price movement after its last earnings report?
CVS Health Corp reported an EPS of €2.01 in its last earnings report, beating expectations of €1.521. Following the earnings report the stock price went up 14.77%.
Which hedge fund is a major shareholder of CVS Health Corp?
Currently, no hedge funds are holding shares in IT:1CVS
---
CVS Health Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$70.87 (31.04% Upside)
$70.87 (31.04% Upside)
Blogger Sentiment
Bullish
IT:1CVS Sentiment 77%
Sector Average 70%
Sector Average 70%
Insider Transactions
Sold Shares
Worth $252.2M over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bearish
Bullish news 0%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
12.17%
12-Months-Change
Fundamentals
Return on Equity
7.00%
Trailing 12-Months
Asset Growth
2.34%
Trailing 12-Months
Company Description
CVS Health Corp
CVS Health Corporation provides health services in the United States. The company's Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. Its Pharmacy Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, clinical, and disease and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, plans offered on public health insurance and private health insurance exchanges, other sponsors of health benefit plans, and individuals. This segment operates retail specialty pharmacy stores; and specialty mail-order, mail-order dispensing, and compounding pharmacies, as well as branches for infusion and enteral nutrition services. The company's Retail/LTC segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products; and provides health care services through its MinuteClinic walk-in medical clinics. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. As of December 31, 2021, it operated approximately 9,900 retail locations and 1,200 MinuteClinic locations, as well as online retail pharmacy websites, LTC pharmacies, and onsite pharmacies. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1963 and is headquartered in Woonsocket, Rhode Island.
---
1CVS Company Deck
---
1CVS Earnings Call
Q1 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
CVS Health delivered strong financial results in Q1 2025 and increased its full-year EPS guidance, reflecting solid performance across all segments. The company is leading in market innovation with expanded access to GLP-1 medications and growth in pharmacy market share. However, challenges persist in individual exchange products, legislative impacts in Arkansas, and elevated medical cost trends. The overall sentiment is cautiously optimistic with strong highlights, but significant lowlights remain.Read More>---
1CVS Revenue Breakdown
46.57% Health Services
35.05% Health Care Benefits
33.40% Pharmacy & Consumer Wellness
0.12% Corporate/ Other
---
1CVS Stock 12 Month Forecast
Average Price Target
€70.87
▲(31.04% Upside)
Technical Analysis
---